January 2015 Issue of The Ophthalmologist

Commodity parts, powerful processors and clever algorithms are changing ophthalmology – cheaply.

Gene therapy could provide long-term relief from elevated nocturnal IOP

Are flexible, battery- and wire-less, light-sensitive nanotube films the future of retinal implants?

Increasing the intensity of illumination degrades the efficacy of regular CXL, but it doesn’t seem to with PACK-CXL. Why?

Ophthalmic surgery is surprisingly flammable.

Remember Allergan’s eyeing-up of Salix

Could your career be a victim of mobbing?

CZM invests an undisclosed amount in Oraya over a two-year period to facilitate Oraya’s growth strategy

Inexpensive yet excellent virtual reality headsets are here – and are about to profoundly transform ophthalmology.

Trimming down the number of concomitant topical glaucoma medications your patients need with MIGS devices could lead to happier patients with better-controlled IOP.

My experience with Keraring intrastromal corneal ring segments in corneal ectasia

What does analysis of the last five years of literature on retinopathy of prematurity tell us?

Getting your medical device the CE certification it needs to break into the European market takes a lot of effort – but it’s worth it

More and more women are entering medicine – but after all their work to get there, why are they reluctant to take the reins?

More women have been entering the profession for decades – but is that being reflected in the literature?

Sitting Down With… Bruce Allan, Consultant Ophthalmic Surgeon and Service Director of the Refractive Surgery Service at Moorfields Eye Hospital, London, UK.